No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life

AIM: Cerebral hypoxia has been associated with neurodevelopmental impairment. We studied whether reducing cerebral hypoxia in extremely preterm infants during the first 72 hours of life affected neurological outcomes at two years of corrected age. METHODS: In 2012‐2013, the phase II randomised Safeg...

Descripción completa

Detalles Bibliográficos
Autores principales: Plomgaard, Anne M., Alderliesten, Thomas, van Bel, Frank, Benders, Manon, Claris, Olivier, Cordeiro, Malaika, Dempsey, Eugene, Fumagalli, Monica, Gluud, Christian, Hyttel‐Sorensen, Simon, Lemmers, Petra, Pellicer, Adelina, Pichler, Gerhard, Greisen, Gorm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585779/
https://www.ncbi.nlm.nih.gov/pubmed/29908039
http://dx.doi.org/10.1111/apa.14463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585779/
https://www.ncbi.nlm.nih.gov/pubmed/29908039
http://dx.doi.org/10.1111/apa.14463

Ejemplares similares